share_log
Breakings ·  Sep 25 18:01
2Seventy Bio Sees Q3 Abecma U.S. Revenue Growth of About 30% From Q2 Revenue of $54 Mln
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment